A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
Clinical trial NCT01218009 · TERMINATED
Trial details
- NCT number
- NCT01218009
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-12-01
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.